Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALBA: Triamcinolone or Bevacizumab with Laser for DME
NCT01572350Phase 3Completed
- Sponsor
- Hospital Universitario de Canarias
- Start
- Oct 2010
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide, bevacizumab in diabetic macular edema (DME), sponsored by Hospital Universitario de Canarias. Started Oct 2010; status: completed.
02
Drugs
triamcinolone acetonidebevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01572350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01572350.